Christopher P. Stewart - 12 May 2023 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Reporting relationship: Chief Financial Officer
Issuer ticker: BNGO
Reported as of: 12 May 2023
Net transaction value: +$33,415
SEC form: 4
Accepted by SEC: 16 May 2023, 18:22:21 UTC
Prior SEC filing: 17 Feb 2023
Next SEC filing: 13 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Christopher P. Stewart

Key filing fact

Christopher P. Stewart filed Form 4 for Bionano Genomics, Inc. (BNGO) on 16 May 2023.

Key facts

This page summarizes Christopher P. Stewart's Form 4 filing for Bionano Genomics, Inc. (BNGO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 May 2023, 18:22.

Change

Previous filing in this sequence was filed on 17 Feb 2023.
Current net transaction value: +$33,415.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BNGO transaction

Common Stock

Purchase

Transaction value: $33,415
Shares: +50,000
Change %: +22%
Price: $0.6683
Shares after: 281,373
Date: 12 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6682 to $0.6683, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.